The Cooper Companies, Inc.

Valuation Analysis

About the Company

The Cooper Companies, Inc. en bref

The Cooper Companies, Inc. (COO) is currently trading at 57,46 € with a market capitalization of 11,2 Md €. The trailing P/E ratio stands at 55.86x, with a forward P/E of 13.18x. The 52-week range spans from 51,34 € to 78,31 €; the current price is 26.6% below the yearly high. Year-over-year revenue growth stands at +7.9%. The net profit margin stands at 5.57%.

💰 Dividende

The Cooper Companies, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

14 analystes évaluent The Cooper Companies, Inc. (COO) au consensus : Acheter. L'objectif de cours moyen est de 70,24 €, soit un potentiel de +22.24% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 57,54 € à 80,20 €.

The Cooper Companies, Inc. : la thèse d'investissement en détail

The Cooper Companies, Inc. (COO) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 65.55%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Wall Street consensus sits at Buy with an average price target implying roughly 22.24% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

With a PEG ratio of 0.67, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

• The forward P/E of 13.18x is meaningfully below the trailing 55.86x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 22.24% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy The Cooper Companies, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.